(Q39648432)

13 September 2017

title

Thrombin is a therapeutic target for metastatic osteopontin-positive hepatocellular carcinoma (English)

1 reference

13 September 2017

Yu-Hua Xue

1

1 reference

13 September 2017

Xiao-Fei Zhang

2

1 reference

13 September 2017

Qiong-Zhu Dong

3

1 reference

13 September 2017

Jian Sun

4

1 reference

13 September 2017

Chun Dai

5

1 reference

13 September 2017

Hai-Jun Zhou

6

1 reference

13 September 2017

Ning Ren

7

1 reference

13 September 2017

Hu-Liang Jia

8

1 reference

13 September 2017

Qin-Hai Ye

9

1 reference

13 September 2017

Lun-Xiu Qin

10

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 October 2010

1 reference

13 September 2017

1 reference

13 September 2017

volume

52

1 reference

13 September 2017

issue

6

1 reference

13 September 2017

page(s)

2012-2022

1 reference

Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain

13 September 2017

cites work

1 reference

The role of Osteopontin in tumor metastasis

21 January 2018

1 reference

7 January 2021

Systemic endocrine instigation of indolent tumor growth requires osteopontin

1 reference

7 January 2021

The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma

1 reference

7 January 2021

Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning

1 reference

7 January 2021

Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma

1 reference

7 January 2021

Osteopontin N-terminal domain contains a cryptic adhesive sequence recognized by alpha9beta1 integrin

1 reference

7 January 2021

The integrin alpha(9)beta(1) binds to a novel recognition sequence (SVVYGLR) in the thrombin-cleaved amino-terminal fragment of osteopontin

1 reference

7 January 2021

Cell migration promoted by a potent GRGDS-containing thrombin-cleavage fragment of osteopontin

1 reference

7 January 2021

The activation state of alphavbeta 3 regulates platelet and lymphocyte adhesion to intact and thrombin-cleaved osteopontin

1 reference

7 January 2021

Thrombin-cleaved COOH(-) terminal osteopontin peptide binds with cyclophilin C to CD147 in murine breast cancer cells

1 reference

7 January 2021

Thrombin-cleaved osteopontin in synovial fluid of subjects with rheumatoid arthritis.

1 reference

7 January 2021

Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype

1 reference

7 January 2021

Role of endogenous thrombin in tumor implantation, seeding, and spontaneous metastasis

1 reference

7 January 2021

Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma

1 reference

7 January 2021

Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

1 reference

7 January 2021

Design and endpoints of clinical trials in hepatocellular carcinoma.

1 reference

7 January 2021

Suitable reference genes for real-time PCR in human HBV-related hepatocellular carcinoma with different clinical prognoses

1 reference

7 January 2021

Role of the integrin-binding protein osteopontin in lymphatic metastasis of breast cancer

1 reference

7 January 2021

New drugs for the treatment of hepatocellular carcinoma.

1 reference

7 January 2021

Structural requirements for alpha 9 beta 1-mediated adhesion and migration to thrombin-cleaved osteopontin

1 reference

7 January 2021

Thrombin induces tumor invasion through the induction and association of matrix metalloproteinase-9 and beta1-integrin on the cell surface

1 reference

7 January 2021

Focal adhesion kinase (p125FAK): a point of convergence in the action of neuropeptides, integrins, and oncogenes

1 reference

7 January 2021

Control of adhesion-dependent cell survival by focal adhesion kinase

1 reference

7 January 2021

Integrin beta1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs

1 reference

7 January 2021

Role of expression of focal adhesion kinase in progression of hepatocellular carcinoma

1 reference

7 January 2021

Abnormalities of blood coagulation in patients with cancer. Fibrinopeptide A generation and tumor growth

1 reference

7 January 2021

Epidemiology of thrombosis in cancer

1 reference

7 January 2021

Risk of arterial thromboembolic events with sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials

1 reference

7 January 2021

Molecular targeted therapies in hepatocellular carcinoma

1 reference

7 January 2021

Anticoagulants in cancer treatment: malignancy as a solid phase coagulopathy

1 reference

7 January 2021

The thrombin inhibitor Argatroban reduces breast cancer malignancy and metastasis via osteopontin-dependent and osteopontin-independent mechanisms

1 reference

7 January 2021

Deep vein thrombosis in cancer: the scale of the problem and approaches to management

1 reference

7 January 2021

Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics

1 reference

7 January 2021

https://api.fatcat.wiki/v0/release/gph5jstafrbe7gwkrhyup3gyhm

Identifiers

1 reference

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_gph5jstafrbe7gwkrhyup3gyhm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gph5jstafrbe7gwkrhyup3gyhm

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/gph5jstafrbe7gwkrhyup3gyhm

1 reference

30 July 2022